Euromedis Groupe SA (ALEMG) - Total Liabilities
Based on the latest financial reports, Euromedis Groupe SA (ALEMG) has total liabilities worth €23.04 Million EUR (≈ $26.94 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Euromedis Groupe SA - Total Liabilities Trend (2009–2025)
This chart illustrates how Euromedis Groupe SA's total liabilities have evolved over time, based on quarterly financial data. See Euromedis Groupe SA (ALEMG) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Euromedis Groupe SA Competitors by Total Liabilities
The table below lists competitors of Euromedis Groupe SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BALAXI PHARMACEUTICALS LIMITED
NSE:BALAXI
|
India | Rs844.30 Million |
|
EcoBio Holdings Co. Ltd
KQ:038870
|
Korea | ₩34.64 Billion |
|
Klimator AB
ST:KLIMAT
|
Sweden | Skr20.33 Million |
|
MSCM Holdings Bhd
KLSE:0041
|
Malaysia | RM78.65 Million |
|
Mlk Foods Public Company Ltd
WAR:MLK
|
Poland | zł154.09 Million |
|
TCS Group Holdings Bhd
KLSE:0221
|
Malaysia | RM197.29 Million |
|
Investsmart Group Ltd
AU:INV
|
Australia | AU$6.41 Million |
|
In8bio Inc
NASDAQ:INAB
|
USA | $3.48 Million |
Liability Composition Analysis (2009–2025)
This chart breaks down Euromedis Groupe SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALEMG market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Euromedis Groupe SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Euromedis Groupe SA (2009–2025)
The table below shows the annual total liabilities of Euromedis Groupe SA from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €23.04 Million ≈ $26.94 Million |
+3.31% |
| 2024-12-31 | €22.30 Million ≈ $26.08 Million |
-5.76% |
| 2023-12-31 | €23.67 Million ≈ $27.67 Million |
-5.28% |
| 2022-12-31 | €24.99 Million ≈ $29.21 Million |
-20.63% |
| 2021-12-31 | €31.48 Million ≈ $36.81 Million |
-41.36% |
| 2020-12-31 | €53.69 Million ≈ $62.77 Million |
+26.31% |
| 2019-12-31 | €42.50 Million ≈ $49.69 Million |
+46.10% |
| 2018-12-31 | €29.09 Million ≈ $34.01 Million |
-1.19% |
| 2017-12-31 | €29.44 Million ≈ $34.42 Million |
+5.36% |
| 2016-12-31 | €27.94 Million ≈ $32.67 Million |
0.00% |
| 2015-12-31 | €27.95 Million ≈ $32.67 Million |
-6.42% |
| 2014-12-31 | €29.86 Million ≈ $34.91 Million |
-5.18% |
| 2013-12-31 | €31.49 Million ≈ $36.82 Million |
-7.10% |
| 2012-12-31 | €33.90 Million ≈ $39.63 Million |
-5.80% |
| 2011-12-31 | €35.99 Million ≈ $42.07 Million |
-3.15% |
| 2010-12-31 | €37.16 Million ≈ $43.44 Million |
+2.73% |
| 2009-12-31 | €36.17 Million ≈ $42.28 Million |
-- |
About Euromedis Groupe SA
Laboratoires Euromedis Société anonyme manufactures, imports, and distributes single-use medical devices for public and private healthcare facilities. It provides gloves; clothing and protection; draping and fields; compresses, cotton, dressings, strips and nets, and skincare products; sets and instrumentation; needles, syringes, microperfusionists; infusion and transfusion services, catheters, a… Read more